Bruton’s tyrosine kinase inhibition reduces disease severity in a model of secondary progressive autoimmune demyelination
Abstract Bruton’s tyrosine kinase (BTK) is an emerging target in multiple sclerosis (MS). Alongside its role in B cell receptor signaling and B cell development, BTK regulates myeloid cell activation and inflammatory responses. Here we demonstrate efficacy of BTK inhibition in a model of secondary p...
Main Authors: | Kirsten Scarlett Evonuk, Sen Wang, Josh Mattie, C. J. Cracchiolo, Reine Mager, Željko Ferenčić, Ethan Sprague, Brandon Carrier, Kai Schofield, Evelyn Martinez, Zachary Stewart, Tara Petrosino, Gregory Andrew Johnson, Isharat Yusuf, Warren Plaisted, Zachary Naiman, Timothy Delp, Laura Carter, Suzana Marušić |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-07-01
|
Series: | Acta Neuropathologica Communications |
Subjects: | |
Online Access: | https://doi.org/10.1186/s40478-023-01614-w |
Similar Items
-
Fulminant inflammatory demyelination presenting as stroke‐in‐evolution in an elderly subject
by: Simone Sacco, et al.
Published: (2021-08-01) -
The role and potential therapeutic targets of astrocytes in central nervous system demyelinating diseases
by: Rui Tan, et al.
Published: (2023-09-01) -
Recurrent tumefactive demyelinating lesions in an elderly woman
by: Erika L. Weil, MD, et al.
Published: (2022-12-01) -
Implication of Contactins in Demyelinating Pathologies
by: Ilias Kalafatakis, et al.
Published: (2021-01-01) -
Exosome-specific loading Sox10 for the treatment of Cuprizone-induced demyelinating model
by: Jin He, et al.
Published: (2024-02-01)